Renal dysfunction, hemodialysis, ICU admission, and antithrombotic therapy showed numerical associations with bleeding risk but did not reach statistical significance after adjustment.
← all excerpts
Tigecycline-Associated Hypofibrinogenemia and Major Bleeding: Incidence, Predictors, and Clinical Outcomes in a Retrospective Cohort.
1
—
—